Novavax NVAX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $240.63M-54.6% | $530.23M-6.7% | $568.51M-57.5% | $1.34B-11.8% | ||
| $494.45M+25.9% | $392.89M— | $0— | —— | ||
| $45.56M+7.6% | $42.34M-74.9% | $168.96M-65.0% | $482.06M+5,334% | ||
| $978.28M-13.3% | $1.13B-1.3% | $1.14B-32.8% | $1.7B-21.0% | ||
| $44.8M-67.6% | $138.41M-54.7% | $305.77M+3.9% | $294.25M+30.3% | ||
| $113.46M+5.6% | $107.48M-15.7% | $127.45M+0.9% | $126.33M-3.9% | ||
| $1.18B-24.6% | $1.56B-13.2% | $1.8B-20.4% | $2.26B-12.3% | ||
| $24.58M-40.9% | $41.58M-68.6% | $132.61M-38.8% | $216.52M+70.4% | ||
| $140.05M-79.3% | $675.07M+180% | $241.31M-34.8% | $370.14M-73.6% | ||
| $2.51M-64.2% | $7.01M+36.3% | $5.14M-81.1% | $27.2M-79.2% | ||
| $459.95M-60.2% | $1.15B-29.4% | $1.64B-33.5% | $2.46B+2.9% | ||
| $244.21M— | —— | —— | —— | ||
| $1.3B-40.3% | $2.18B-13.1% | $2.51B-13.1% | $2.89B-1.2% | ||
| $1.65M+1.9% | $1.62M+15.2% | $1.41M+61.9% | $868K+13.6% | ||
| -$4.57B+8.8% | -$5.01B-3.9% | -$4.82B-12.7% | -$4.28B-18.2% | ||
| -$127.75M+79.5% | -$623.84M+13.0% | -$716.93M-13.1% | -$634.08M-80.3% | ||
| $1.18B-24.6% | $1.56B-13.2% | $1.8B-20.4% | $2.26B-12.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Novavax's total assets?
- Novavax (NVAX) holds $1.0B in total assets, down 19.3% year over year.
- How much debt does Novavax have?
- Novavax carries $295.1M in total debt against -$144.8M of shareholders' equity, a debt-to-equity ratio of 1.54.
- How much cash does Novavax have?
- Novavax holds $228.4M in cash and equivalents.
- Can Novavax cover its short-term obligations?
- Its current ratio is 2.48 — current assets exceed current liabilities.
- Where does Novavax's balance sheet data come from?
- Every line is extracted from Novavax's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
